Skip to main content
. 2025 Aug 13;15:69. doi: 10.1186/s13561-025-00669-w

Table 2.

Base-case results

RDN groups Control groups Differences Relative risk
Number of events
 CHD 60 83 -23 0.72
  AMI 47 64 -17 0.73
  HF 21 30 -9 0.70
  SCD 13 18 -5 0.72
 Stroke 255 370 -115 0.69
  IS 132 191 -60 0.69
  HS 123 178 -56 0.69
 TIA 105 152 -47 0.69
 ESRD 13 19 -6 0.68
 Cardiovascular, stroke, and renal event mortality 116 164 -48 0.71
Discount rate at 5%
Mean LYs 14.27 13.95 0.32 -
Mean QALYs 13.27 12.90 0.37 -
Mean costs per person ($)
 Mainland China 17,260 10,170 7091 -
 Japan 34,592 28,703 5889 -
 Thailand 10,994 4099 6896 -
ICER ($/QALY)
 Mainland China 19,049
 Japan 15,821
 Thailand 18,525
ICER ($/LY)
 Mainland China 22,046
 Japan 18,310
 Thailand 21,410
Discount rate at 3%
Mean LYs 17.47 17.02 0.45
Mean QALYs 16.23 15.72 0.51
Mean costs per person ($)
 Mainland China 19,586 12,722 6864
 Japan 41,542 37,953 3589
 Thailand 12,287 5190 7097
ICER ($/QALY)
 Mainland China 15,254
 Japan 7046
 Thailand 13,932
ICER ($/LY)
 Mainland China 14,927
 Japan 8013
 Thailand 15,845
Discount rate at 2%
Mean LYs 19.53 19.00 0.53
Mean QALYs 18.13 17.53 0.60
Mean costs per person ($)
 Mainland China 21,105 14,388 6717
 Japan 46,183 44,105 2079
 Thailand 13,117 5887 7230
ICER ($/QALY)
 Mainland China 11,153
 Japan 3451
 Thailand 12,005
ICER ($/LY)
 Mainland China 12,674
 Japan 3894
 Thailand 13,544

AMI, acute myocardial infarction; CHD, coronary heart disease; ESRD, end-stage renal disease; HF, heart failure; HS, hemorrhagic stroke; ICER, incremental cost-effectiveness ratio; IS, ischemic stroke; LY: life year; SCD, sudden cardiac death; QALY, quality-adjusted life year; RDN, renal denervation; TIA, transient ischemic attacks